The antigens targeted by these autoreactive melanocyte-specific cytotoxic lymphocytes derived from proteins of the melanogenic pathway, such as gp100, (Melanoma antigen recognized by T cells 1) MART1, tyrosinase, and tyrosinase-related proteins 1 and 2, thus mediating melanocyte destruction [57]. The gene discussed is PMEL; the disease is melanoma.